Helius Medical Technologies Inc (HSDT) News

Helius Medical Technologies, Inc. Announces Preliminary CMS Payment Determination of Reimbursement for Portable Neuromodulation Stimulator (PoNS®)

-- The Centers for Medicare & Medicaid Services (CMS) released its preliminary Medicare payment...

Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center

-- Helius Medical and Shepherd Center partner on a study that aims at rehabilitating walking mobility in people...

Helius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™

-- Lovell is an approved supplier to the U.S. Department of Veterans Affairs (VA) and Department of Defense...

Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

-- Company to host call at 4:30pm today -- NEWTOWN, Pa., March 28, 2024 (GLOBE NEWSWIRE) -- Helius Medical...

Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024

NEWTOWN, Pa., March 15, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius”...

Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke

-- Enrollment of at least ten patients at Brooks Rehabilitation will begin this month Study will evaluate the...

Helius Medical Technologies, Inc. to Present at the 36th Annual ROTH Conference

NEWTOWN, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or...

Form 8-K - Current report

Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller

-- Significant step toward reimbursement for the only medical device approved in the U.S. for treatment of gait...

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Form 8-K - Current report

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Helius Medical Technologies, Inc. Announces Alignment with FDA on Registrational Program for Treatment of Stroke Patients

-- Studies uses Portable Neuromodulation Stimulator (PoNS®) to evaluate cranial-nerve non-invasive...

Helius Booth and Special Event at APTA Combined Sections Meeting Will Highlight Physical Therapists’ Ability to Customize PoNS Therapy® to Improve Gait in People with MS

NEWTOWN, Pa., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) is expanding...

Helius Medical Technologies, Inc. Announces Further Expansion of Stroke Clinical Program with the Addition of Brooks Rehabilitation Hospital

-- Brooks Rehabilitation Hospital adds a second site to the registrational program in stroke, and brings the...